<?xml version="1.0" encoding="UTF-8"?>
<p id="p0145">Pharmacokinetic evaluation was performed at all dosing points in part 1 of the study and after the first and last administrations of JR-141 in part 2. The time points for blood sampling were before dosing, 1 hr after the start of dosing, immediately after the last administration, and then 3, 9, and 21 hr afterward. Drug concentrations were measured by an electrochemiluminescence assay.</p>
